ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Gets Long List Of Consortium Center Needs, Including New Guidelines, Review, More “Glue”

September 14, 1984

Cooperation Is ACS Theme For ‘90s; Dodd

February 1, 1991

Progress Requires More Etiologists, D’Angio Says

September 15, 1978

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

Palmetto Establishes Coverage For Thyroid Genomic Test

January 27, 2012